Through the study of LRRK2 gene polymorphism in patients with PD in mainland China, Yu et al(12) observed that the incidence of the R1628P site was 5.2% and the onset risk of PD increased 2.678-fold. This evidence concerns the gene LRRK2 and Parkinson disease.